Skip to main content
. 2016 Nov 30;8(5):119–122. doi: 10.1002/cld.585

Figure 1.

Figure 1

Pathogenesis and epidemiology of NAFLD/NASH‐related HCC. Prevalence rates are given for the population of the United States. HCC prevalence rates are related to patients with NAFLD/NASH (see Table 1). The long arrow indicates that HCC also can develop in patients with NAFLD/NASH who do not have cirrhosis.